Abrdn Life Science Investors (NASDAQ:HQL) | WebDisclosure

Switch to English

10651	Sociétés
226542	Mots-clés
155028	Articles
119935	Communiqués

Accueil
Sociétés
Abrdn Life Science Investors

COMMUNIQUÉ DE PRESSE

publié le 09/02/2024 à 23:23, il y a 2 années 4 mois

abrdn Life Sciences Investors (HQL) and abrdn Healthcare Investors (HQH) Announce a 25% Increase in Distribution Rates and abrdn Healthcare Opportunities Fund (THQ) Announces a 60% Increase in Distribution Rate
abrdn Life Sciences Investors (HQL), abrdn Healthcare Investors (HQH), and abrdn Healthcare Opportunities Fund (THQ) have approved an increase in each Fund's distribution rate and announce payment details for the Funds. The Boards consider strong long term positive total return and the outlook on the healthcare sector

Healthcare Sector Abrdn Life Sciences Investors Abrdn Healthcare Investors Abrdn Healthcare Opportunities Fund Distribution Rate

Les Echos

Publié le 26/06/2026 à 17:45, il y a 13 heures 56 minutes

Combined General Meeting, June 25, 2026
Publié le 26/06/2026 à 17:45, il y a 13 heures 56 minutes

Assemblée générale mixte du 25 juin 2026
Publié le 26/06/2026 à 17:45, il y a 13 heures 56 minutes

Descriptif du programme de rachat d'actions
Publié le 26/06/2026 à 14:44, il y a 16 heures 56 minutes

Safran information
Publié le 26/06/2026 à 14:44, il y a 16 heures 56 minutes

Information Safran

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 27/06/2026 à 01:40, il y a 6 heures 1 minute

Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Publié le 27/06/2026 à 00:00, il y a 7 heures 41 minutes

Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Publié le 26/06/2026 à 23:00, il y a 8 heures 41 minutes

Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Publié le 26/06/2026 à 22:50, il y a 8 heures 51 minutes

Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Publié le 26/06/2026 à 22:15, il y a 9 heures 26 minutes

Revive Therapeutics Announces Proposed Private Placement

Voir tout ACCESSWIRE

EQS Group

Publié le 27/06/2026 à 00:05, il y a 7 heures 35 minutes

EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Publié le 27/06/2026 à 00:04, il y a 7 heures 36 minutes

Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Publié le 26/06/2026 à 23:36, il y a 8 heures 5 minutes

Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Publié le 26/06/2026 à 23:36, il y a 8 heures 5 minutes

EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Publié le 26/06/2026 à 23:27, il y a 8 heures 13 minutes

EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE